Base de dados : HANSEN
Pesquisa : SULFONAS/SANGUE [Descritor de assunto]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 HANSEN  
              next record last record
seleciona
para imprimir
Id:22335
Autor:Anon.
Título:Reports: Annual report for 1950 of the Hind Kusht Nivaran Sangh (Indian Leprosy Association). Part 1 - Report of the Chairman. Part 2 - Research activities.
Fonte:Lepr Ind;23(3):169-79, july. 1951. .
Descritores:HANSENIASE/prev
HANSENIASE/psicol
HANSENIASE/reabil
HANSENIASE/quimioter
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/sangue
SULFONAS/uso terap
Localização:BR191.1


  2 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:22216
Autor:Fernandez, Jose M. M; Carboni, Eduardo A.
Título:The action of diasone in the treatment of leprosy: preliminary report.
Fonte:Int. J. Lepr;14(n.esp):19-29, Dec. 1946. tab, ilus.
Resumo:The action of the oral administration of diasone has been studied in a group of advanced cases of leprosy of whom almost all had previously been treated with chaulmoogra oil. The drug was given for periods of 8 weeks with a daily dosage varying between 1 and 3 Grams according to individual tolerance; between each period or course of treatment there was a 4 weeks' interval. Anemia (82 per cent), asthenia and depression (88 per cent), headache (74 per cent) were noted as signs of intolerance. There were no grave consequences and intolerance was readily treated with liver extract, iron, and vitamin B complex. Activity of the drug was shown by softening, ulceration, and re-absorption of leprous nodules, healing of ulcers, and re-absorption of deep lepromatous infiltrations. Bacteriologically, granulation of the bacilli was observed but in no case had bacilli completely disappeared from the lesions. The improvement noted was greater the longer and more concentrated the treatment. The results found after 8 months trial were the following: in 5 cases treated for 3 periods, 100 per cent improved; in 11 cases treated for 2 periods, 63.6 per cent improved; in 26 cases after only 1 period of treatment, 50 per cent improved. Thus of 42 patients who had completed 1 to 3 periods of treatment, 59.5 per cent showed improvement. Finally it may be stated that diasone has proved to be effective in the treatment of leprosy in a series of 42 patients observed for 8 months. Further experimental treatment should be carried out so that definite conclusions based on greater experience can be obtained. (AU).
Descritores:HANSENIASE/quimioter
HANSENOSTATICOS/hist
SULFONAS/admin
SULFONAS/ef adv
SULFONAS/sangue
SULFONAS/sint quim
SULFONAS/farmacol
SULFONAS/uso terap
Limites:HUMANO
Localização:BR191.1


  3 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-pt
Id:8928
Autor:Beiguelman, Bernardo; Pisani, R. C. B.
Título:Chromosomal aberrations in leucocyte metaphases of leprosy patients under dapsone therapy.
Fonte:Hansen. Int;1(1):53-60, 1976. tab.
Resumo:Chromosome analyses were made on leukocyte metaphases of 18 leprosy patients who were ingesting daily doses of 50 mg or 100 mg of DDS and of 40 healthy individuals used for control. These analyses have shown that the proportion of numerical chromosomal aberrations in the leukocyte metaphases of the leprosy patients did not differ significantly from that observed in the cells of the controls. In contrast, the frequency of cells with chromatid or chromosome breaks and gaps was significantly increased in the leukocytesof leprosy patients. Multiple regression analysis applied to the data recorded has shown that the increase of breaks and gaps in the chromosomes of leprosy patients can not be attributed to age, years under sulfonetherapy or to concentration of DDS in blood..
Descritores:HANSENIASE
HANSENIASE
HANSENIASE
SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 SULFONAS
 ABERRAÇOES CROMOSSOMICAS
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/hansenint/v01aov20/1976/PDF/v1n1/v1n1a05.pdf - pt.
Localização:BR191.1


  4 / 4 HANSEN  
              first record previous record
seleciona
para imprimir
Id:503
Autor:Gordon, G. R; Murray Junior, J. F; Peters, J. H.
Título:Measurement of N, N'-diacetyldiaminodiphenyl sulfone (DAAS) in the plasma of leprosy patients treated with DADDS.
Fonte:In: Annual Leprosy Research Conference, 6.Annual Leprosy Research Conference, 6/Abstracts. Atlanta, Center for Disease Control, 1971. p.16.
Conferência:Apresentado em: Annual Leprosy Research Conference, 6, Atlanta, 10-12 March 1971.
Descritores:SULFONAS
SULFONAS
SULFONAS
SULFONAS
ANALISE MICROBIOLOGICA
Localização:BR191.1; WC335.3, A78a



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information